Mark Shapiro

1.1k total citations
24 papers, 686 citations indexed

About

Mark Shapiro is a scholar working on Psychiatry and Mental health, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Shapiro has authored 24 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Psychiatry and Mental health, 3 papers in Surgery and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Shapiro's work include Glioma Diagnosis and Treatment (2 papers), Brain Metastases and Treatment (2 papers) and Pharmaceutical studies and practices (2 papers). Mark Shapiro is often cited by papers focused on Glioma Diagnosis and Treatment (2 papers), Brain Metastases and Treatment (2 papers) and Pharmaceutical studies and practices (2 papers). Mark Shapiro collaborates with scholars based in United States, Germany and Australia. Mark Shapiro's co-authors include Susan G. Silva, John S. March, Scott N. Compton, Ranga Krishnan, Robert M. Califf, Bruce E. Sands, Michael Safdi, Bruce Salzberg, Lawrence D. Wruble and Charles F. Barish and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and American Journal of Psychiatry.

In The Last Decade

Mark Shapiro

24 papers receiving 648 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Shapiro United States 11 202 170 167 113 81 24 686
Dubhfeasa Slattery Ireland 14 89 0.4× 85 0.5× 206 1.2× 25 0.2× 153 1.9× 34 950
Vu Q. Nguyen United States 15 177 0.9× 233 1.4× 49 0.3× 61 0.5× 181 2.2× 58 814
Stephen Hearing United Kingdom 14 248 1.2× 237 1.4× 114 0.7× 49 0.4× 135 1.7× 28 831
Laura Marín Spain 11 316 1.6× 212 1.2× 117 0.7× 48 0.4× 171 2.1× 22 562
Bo Nancy Yu Canada 16 56 0.3× 242 1.4× 29 0.2× 118 1.0× 64 0.8× 27 993
Keith Benkov United States 24 501 2.5× 396 2.3× 215 1.3× 119 1.1× 478 5.9× 75 1.5k
Réme Mountifield Australia 14 348 1.7× 218 1.3× 241 1.4× 53 0.5× 289 3.6× 34 770
S. Leone Italy 13 165 0.8× 130 0.8× 60 0.4× 14 0.1× 53 0.7× 42 456
Joan McDowell United Kingdom 14 36 0.2× 117 0.7× 148 0.9× 62 0.5× 42 0.5× 42 811
Vittorio Basevi Italy 10 98 0.5× 94 0.6× 74 0.4× 24 0.2× 44 0.5× 16 628

Countries citing papers authored by Mark Shapiro

Since Specialization
Citations

This map shows the geographic impact of Mark Shapiro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Shapiro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Shapiro more than expected).

Fields of papers citing papers by Mark Shapiro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Shapiro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Shapiro. The network helps show where Mark Shapiro may publish in the future.

Co-authorship network of co-authors of Mark Shapiro

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Shapiro. A scholar is included among the top collaborators of Mark Shapiro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Shapiro. Mark Shapiro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Castro, Michael, et al.. (2024). Proton pump inhibitors are detrimental to overall survival of patients with glioblastoma: Results from a nationwide real-world evidence database. Neuro-Oncology Practice. 11(6). 713–722. 1 indexed citations
3.
Stuhlmiller, Timothy J., Fábio M. Iwamoto, Burt Nabors, et al.. (2023). IMMU-39. EFFICACY OF IMMUNE CHECKPOINT INHIBITORS IN GLIOBLASTOMA FROM REAL-WORLD DATA ANALYSIS. Neuro-Oncology. 25(Supplement_5). v151–v151. 1 indexed citations
4.
Lazaridis, Christos, Ali Mansour, David O. Okonkwo, et al.. (2022). Prediction of Intracranial Hypertension and Brain Tissue Hypoxia Utilizing High-Resolution Data from the BOOST-II Clinical Trial. SHILAP Revista de lepidopterología. 3(1). 473–478. 6 indexed citations
5.
Wasserman, Asher, et al.. (2022). Virtual Trials: Causally-validated treatment effects efficiently learned from an observational cancer registry. Artificial Intelligence in Medicine. 135. 102450–102450. 1 indexed citations
6.
Duane, Therèse M., Jared M. Huston, Sara E. Parli, et al.. (2021). Surgical Infection Society 2020 Updated Guidelines on the Management of Complicated Skin and Soft Tissue Infections. Surgical Infections. 22(4). 383–399. 41 indexed citations
7.
Shapiro, Mark, et al.. (2019). Evaluation of high-risk pulmonary nodules and pathologic correlation in patients enrolled in a low-dose computed tomography (LDCT) program. Journal of Thoracic Disease. 11(4). 1165–1169. 5 indexed citations
8.
Shrager, Jeff, Mark Shapiro, & William Hoos. (2019). Is Cancer Solvable? Towards Efficient and Ethical Biomedical Science. The Journal of Law Medicine & Ethics. 47(3). 362–368. 4 indexed citations
9.
Bukoski, Alex, et al.. (2018). Perceptions of Simulator- and Live Tissue-Based Combat Casualty Care Training of Senior Special Operations Medics. Military Medicine. 183(suppl_1). 78–85. 10 indexed citations
10.
Cook, Mackenzie R., et al.. (2012). Daily Temperature Predicts Assault and May Allow More Efficient Policing. The American Surgeon. 78(4). 194–195. 7 indexed citations
11.
DiazGranados, Carlos A., Nancy White, Mark Shapiro, et al.. (2009). Outbreak of Pseudomonas aeruginosa Infection Associated With Contamination of a Flexible Bronchoscope. Infection Control and Hospital Epidemiology. 30(6). 550–555. 49 indexed citations
12.
Shapiro, Mark, Susan G. Silva, Scott N. Compton, et al.. (2009). The child and adolescent psychiatry trials network (CAPTN): infrastructure development and lessons learned. Child and Adolescent Psychiatry and Mental Health. 3(1). 12–12. 15 indexed citations
13.
Wolff, Alice De, et al.. (2009). The Creation of “We Are Neighbours”: Participatory Research and Recovery. Canadian Journal of Community Mental Health. 28(2). 61–72. 2 indexed citations
14.
DeVeaugh-Geiss, Joseph, John S. March, Mark Shapiro, et al.. (2006). Child and Adolescent Psychopharmacology in the New Millennium: A Workshop for Academia, Industry, and Government. Journal of the American Academy of Child & Adolescent Psychiatry. 45(3). 261–270. 23 indexed citations
15.
Herrlinger, Klaus, Andreas Raedler, Bernd Bokemeyer, et al.. (2005). Randomized, Double Blind Controlled Trial of Subcutaneous Recombinant Human Interleukin-11 Versus Prednisolone in Active Crohn's Disease. The American Journal of Gastroenterology. 101(4). 793–797. 62 indexed citations
16.
March, John S., Susan G. Silva, Scott N. Compton, et al.. (2005). The Case for Practical Clinical Trials in Psychiatry. American Journal of Psychiatry. 162(5). 836–846. 156 indexed citations
17.
Sands, Bruce E., Bruce Salzberg, Michael Safdi, et al.. (2002). Randomized, controlled trial of recombinant human interleukin‐11 in patients with active Crohn's disease. Alimentary Pharmacology & Therapeutics. 16(3). 399–406. 106 indexed citations
18.
Rathaus, Valeria, et al.. (2001). Ultrasound features of spermatic cord hydrocele in children. British Journal of Radiology. 74(885). 818–820. 25 indexed citations
19.
Shapiro, Mark, et al.. (2001). The implications of the new capital adequacy rules for portfolio management of credit assets. Journal of Banking & Finance. 25(1). 97–114. 13 indexed citations
20.
Sands, Bruce E., Charles A. Sninsky, Seymour Katz, et al.. (1999). Preliminary evaluation of safety and activity of recombinant human interleukin 11 in patients with active Crohn's disease. Gastroenterology. 117(1). 58–64. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026